Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Targeted radiation beams aim to keep deadly brain tumors at bay

NCT ID NCT05533242

First seen May 23, 2026 · Last updated May 23, 2026

Summary

This early-phase trial tests a new treatment for glioblastoma, an aggressive brain cancer. After standard therapy (surgery, chemo, radiation), a radioactive drug is injected into the brain cavity to target leftover tumor cells and delay recurrence. The study includes 15 adults and focuses on finding the safest dose and measuring how radiation spreads in the body.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for GLIOBLASTOM WHO GRADE 4 are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Contacts and locations

Locations

  • Klinik für Allgemeine Neurochirurgie des Universitätsklinikums Köln

    Cologne, 50937, Germany

  • Klinik für Neurochirurgie des Universitätsklinikums Essen

    Essen, 45147, Germany

  • Klinik für Nuklearmedizin der Universität Münster

    Münster, 48149, Germany

  • Klinik für Nuklearmedizin des Universitätsklinikums Köln

    Cologne, 50937, Germany

  • Klinik für Nuklearmedizin, Strahlenklinik des Universitätsklinikums Essen

    Essen, 45147, Germany

  • Universitätsklinikum Würzburg - Neurochirurgie

    Würzburg, 97080, Germany

  • Universitätsklinikum Würzburg - Nuklearmedizin

    Würzburg, 97080, Germany

Conditions

Explore the condition pages connected to this study.